DMPK

A1 BioChem Labs (ABCL), a subsidiary of Apitoria Pharma Private LTD, is a CRDMO offering comprehensive chemistry services to pharma, biotech, and academia. It operates advanced labs in Wilmington, NC, and Hyderabad, India, specializing in custom synthesis, medicinal chemistry, route scouting, analytical development, and commercial-scale manufacturing across FDA, EDQM, and PMDA approved sites.

analytical developmentchemical sourcingchiral analysisCMC supportcommercial-scale manufacturingcustom synthesisflow chemistrygenotoxic impurity assessmenthigh-vacuum distillationhydrogenationmedicinal chemistrynitrosamine controlparticle-size distributionpolymorphismpowder processingprocess developmentprocess safetyroute scoutingsolid-state analysis

Atavistik Bio is a clinical stage biotechnology company developing novel allosteric therapeutics. Its approach enables selective modulation of disease-causing proteins. The company is advancing multiple programs, including its lead asset ATV-1601, an oral allosteric AKT1-selective inhibitor for Hereditary Hemorrhagic Telangiectasia (HHT), and a JAK2 V617F mutant-selective inhibitor program for myeloproliferative neoplasms. It has built a versatile discovery platform that identifies functional pockets across protein classes, with an internal focus on rare

allosteric drug discoverycheminformaticsclinical developmentCMCmedicinal chemistryRegulatory affairstranslational research

BioAscent is a provider of integrated drug discovery services based at the former Organon/MSD R&D site in Newhouse, Scotland, UK. Founded in 2013, its services include assay development, target analysis, compound screening, medicinal and synthetic chemistry, computational chemistry, DMPK, protein science and compound management, with access to in-house diversity and fragment libraries.

assay developmentbiophysicscompound managementcompound screeningcompound storage and logisticscomputational chemistryhigh-throughput screeningin silico discoveryLC-MSliquid handlingmedicinal chemistryNMRprotein productionpurificationstructural biologysurface plasmon resonancesynthetic chemistry

Broad Capabilities. Boutique Services. Every program deserves a partner, not just a provider. We built Bio Duro to be exactly the right size: broad enough to support your science at every stage, agile enough to move when you need to move, and focused enough to treat your program like the priority it is. Explore Our Capabilities All Company News October 1, 2026 June 6, 2026 May 28, 2026 April 28, 2026 April 23, 2026 March 12, 2026 March 3, 2026 February 10, 2026 January 27, 2026 November 18, 2025 August 20, 2025 July 30, 2025 June 10, 2025 May 8, 2025 April 7, 2025 March 25, 2025 March 5, 2025 January 20, 2025 January 9, 2025 January 6, 2025 October 24, 2024 October 1, 2024 September 16, 2024 All Company News Deliver solutions using enabling technologies like AI enabled molecular design, high throughput screening, DNA-coded library, parallel synthesis. Explore Chemistry Most visited.

AI-assisted molecular designanalytical chemistryAPI manufacturingbioanalysiscomputational chemistryDNA-encoded library screeningdrug product manufacturingformulation developmenthigh-throughput screeningin vitro assaysin vivo modelsmedicinal chemistryparallel synthesispeptide chemistryprocess R&Dscale upsynthetic chemistrytoxicology

FinsnoBio is a biotechnology company rapidly advancing small molecule therapies focused on defined targets and patient populations validated by human genetics, aiming to bring precision medicines to patients with neurodegenerative disease and other serious medical conditions. Its core team of industry professionals and network of academic experts work on genetic targets in neurodegeneration.

chemistryclinical affairssmall molecule therapy developmenttoxicology

Frontage Laboratories, Inc. is a global pharmaceutical development organization (PDO) and CRO providing integrated, science-driven product development services throughout the drug discovery and development process. It assists clients in advancing molecules through development to commercial launch, enabling innovators, generic, and consumer health companies to file IND, NDA, ANDA, BLA, and 505(b)(2) submissions in global markets.

analytical servicesbioanalysisbiostatisticscentral lab servicesclinical trial material manufacturingcommercial manufacturingDART servicesdata managementdrug developmentdrug discoveryformulation developmentgenetic toxicologyGMP routine testingmass spectrometrymethod development and validationsafety pharmacologystability programsstatistical programmingtoxicology